{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T17:05:55Z","timestamp":1786554355475,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,8]]},"DOI":"10.7759\/cureus.57876","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T05:43:53Z","timestamp":1712641433000},"source":"Crossref","is-referenced-by-count":3,"title":["A Case of Miliary Tuberculosis Complicated by Thyroid Involvement: Managing Rifampicin-Induced Thrombocytopenia With Rifabutin"],"prefix":"10.7759","author":[{"given":"Akimichi","family":"Nagashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Imura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumi","family":"Okochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S29179","article-title":"Diagnosis and management of miliary tuberculosis: current state and future perspectives","volume":"9","author":"Ray S","year":"2013","unstructured":"Ray S, Talukdar A, Kundu S, Khanra D, Sonthalia N. Diagnosis and management of miliary tuberculosis: current state and future perspectives. Ther Clin Risk Manag. 2013, 9:9-26. 10.2147\/TCRM.S29179","journal-title":"Ther Clin Risk Manag"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0013-2016","article-title":"Miliary tuberculosis","volume":"5","author":"Sharma SK","year":"2017","unstructured":"Sharma SK, Mohan A. Miliary tuberculosis. Microbiol Spectr. 2017, 5:10.1128\/microbiolspec.TNMI7-0013-2016","journal-title":"Microbiol Spectr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7792","article-title":"High detection rates of urine Mycobacterium tuberculosis in patients with suspected miliary tuberculosis","volume":"56","author":"Yokoyama T","year":"2017","unstructured":"Yokoyama T, Kinoshita T, Okamoto M, et al.. High detection rates of urine Mycobacterium tuberculosis in patients with suspected miliary tuberculosis. Intern Med. 2017, 56:895-902. 10.2169\/internalmedicine.56.7792","journal-title":"Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0139-1","article-title":"Tuberculosis of the thyroid gland: review of the literature","volume":"30","author":"Bulbuloglu E","year":"2006","unstructured":"Bulbuloglu E, Ciralik H, Okur E, Ozdemir G, Ezberci F, Cetinkaya A. Tuberculosis of the thyroid gland: review of the literature. World J Surg. 2006, 30:149-55. 10.1007\/s00268-005-0139-1","journal-title":"World J Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.900858","article-title":"Bidirectional relationship between tuberculosis and hypothyroidism: an 18-year nationwide population-based longitudinal cohort study","volume":"9","author":"Cheng LT","year":"2022","unstructured":"Cheng LT, Chung CH, Peng CK, et al.. Bidirectional relationship between tuberculosis and hypothyroidism: an 18-year nationwide population-based longitudinal cohort study. Front Med (Lausanne). 2022, 9:900858. 10.3389\/fmed.2022.900858","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00003709","article-title":"Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction","volume":"18","author":"Bloch S","year":"2009","unstructured":"Bloch S, Wickremasinghe M, Wright A, Rice A, Thompson M, Kon OM. Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction. Eur Respir Rev. 2009, 18:295-9. 10.1183\/09059180.00003709","journal-title":"Eur Respir Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid P","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, et al.. Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016, 63:e147-95. 10.1093\/cid\/ciw376","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-5-3","article-title":"Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor","volume":"5","author":"Chen J","year":"2006","unstructured":"Chen J, Raymond K. Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. Ann Clin Microbiol Antimicrob. 2006, 5:3. 10.1186\/1476-0711-5-3","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw024","article-title":"Rifabutin: where do we stand in 2016?","volume":"71","author":"Crabol Y","year":"2016","unstructured":"Crabol Y, Catherinot E, Veziris N, Jullien V, Lortholary O. Rifabutin: where do we stand in 2016?. J Antimicrob Chemother. 2016, 71:1759-71. 10.1093\/jac\/dkw024","journal-title":"J Antimicrob Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0068","article-title":"Experience with rifabutin replacing rifampin in the treatment of tuberculosis","volume":"15","author":"Horne DJ","year":"2011","unstructured":"Horne DJ, Spitters C, Narita M. Experience with rifabutin replacing rifampin in the treatment of tuberculosis. Int J Tuberc Lung Dis. 2011, 15:1485-9, i. 10.5588\/ijtld.11.0068","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.33590\/emj\/20-00193","article-title":"Rifampicin-induced thrombocytopenia: a case report and short review of the literature","author":"Koumpis E","year":"2021","unstructured":"Koumpis E, Papathanasiou K, Papakonstantinou I, Tassi I, Serpanou A, Kapsali E, Hatzimichael E. Rifampicin-induced thrombocytopenia: a case report and short review of the literature. Eur Med J. 2021, 10.33590\/emj\/20-00193","journal-title":"Eur Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12214","article-title":"Thrombocytopenia: an update","volume":"36","author":"Smock KJ","year":"2014","unstructured":"Smock KJ, Perkins SL. Thrombocytopenia: an update. Int J Lab Hematol. 2014, 36:269-78. 10.1111\/ijlh.12214","journal-title":"Int J Lab Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268811001476","article-title":"Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak","volume":"140","author":"Lee SH","year":"2012","unstructured":"Lee SH, Yim JJ, Kim HJ, et al.. Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak. Epidemiol Infect. 2012, 140:1028-35. 10.1017\/S0950268811001476","journal-title":"Epidemiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/lungindia.lungindia_401_20","article-title":"Safety of Rifabutin in patients with rifampicin-induced thrombocytopenia","volume":"37","author":"Sarkar T","year":"2020","unstructured":"Sarkar T, Riccardi N, Wagh H, Udwadia ZF. Safety of Rifabutin in patients with rifampicin-induced thrombocytopenia. Lung India. 2020, 37:455-6. 10.4103\/lungindia.lungindia_401_20","journal-title":"Lung India"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/237357-a-case-of-miliary-tuberculosis-complicated-by-thyroid-involvement-managing-rifampicin-induced-thrombocytopenia-with-rifabutin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T05:43:57Z","timestamp":1712641437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/237357-a-case-of-miliary-tuberculosis-complicated-by-thyroid-involvement-managing-rifampicin-induced-thrombocytopenia-with-rifabutin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.57876","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}